Key result
Integrated management strategies are needed to address obesity-linked HF morbidity and mortality.
Why the study?
Obesity is a key contributor to heart failure, driving morbidity and costs, and integrated management strategies are essential given the rising prevalence of both diseases.
This review provides a comprehensive guide on managing patients with both obesity and heart failure, emphasizing the need for integrated strategies spanning lifestyle, pharmacological, and surgical interventions.
Obesity is a key contributor to heart failure, driving increased morbidity, mortality, and healthcare costs. This association is supported by multiple pathophysiological mechanisms and consistent epidemiological evidence, particularly not only in heart failure with preserved ejection fraction (HFpEF), but also in heart failure with reduced ejection fraction (HFrEF). Given the rising prevalence of both diseases, integrated management strategies are essential. This review outlines current management options in patients with heart failure and obesity, from lifestyle modification to pharmacological and surgical treatment, and explores emerging treatments aimed at mitigating this growing burden.
No takes yet. Share an insight, caveat, or question.
Antza et al. (2026) studied this question. Obesity significantly contributes to heart failure morbidity and mortality, necessitating integrated management strategies for affected patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: